Exhibit 10.10
IDEAYA BIOSCIENCES, INC.
EMPLOYMENT AGREEMENT
This Employment Agreement (the “Agreement”) is entered into between IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”) and Darrin Beaupre, M.D., PhD (“Executive” and, together with the Company, the “Parties”) effective as of November 21, 2022 (the “Effective Date”).
WHEREAS, the Company desires to assure itself of the services of Executive by engaging Executive to perform services as an employee of the Company under the terms hereof; and
WHEREAS, Executive desires to provide services to the Company on the terms herein provided effective as of the Effective Date.
NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, including the respective covenants and agreements set forth below, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
1
Exhibit 10.10
2
Exhibit 10.10
3
Exhibit 10.10
4
Exhibit 10.10
5
Exhibit 10.10
6
Exhibit 10.10
7
Exhibit 10.10
8
Exhibit 10.10
9
Exhibit 10.10
10
Exhibit 10.10
11
Exhibit 10.10
12
Exhibit 10.10
[Signature Page Follows]
13
Exhibit 10.10
14
Exhibit 10.10
The Parties have executed this Agreement as of the Effective Date.
IDEAYA BIOSCIENCES, INC.
By:/s/ Yujiro S. Hata
Name: Yujiro S. Hata
Title: President and Chief Executive Officer
EXECUTIVE
By: /s/ Darrin Beaupre
Name: Darrin Beaupre, M.D., PhD
Address:
[PRIVATE ADDRESS]
1
Exhibit 10.10
Exhibit A
PERMITTED OUTSIDE ACTIVITIES
Consulting Services to Biosplice Therapeutics
2
Exhibit 10.10
Exhibit B
RELEASE OF CLAIMS
This Release of Claims (“Release”) is entered into as of _________________, 20__, between [__________] (“Executive”) and IDEAYA Biosciences, Inc., a Delaware corporation (the “Company” and, together with Executive, the “Parties”), effective eight days after Executive’s signature hereto (the “Effective Date”), unless Executive revokes his acceptance of this Release as provided in Paragraph 1(c), below.
3
Exhibit 10.10
4
Exhibit 10.10
“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.”
BEING AWARE OF SAID CODE SECTION, EXECUTIVE HEREBY EXPRESSLY WAIVES ANY RIGHTS EXECUTIVE MAY HAVE THEREUNDER, AS WELL AS UNDER ANY OTHER STATUTES OR COMMON LAW PRINCIPLES OF SIMILAR EFFECT.
5
Exhibit 10.10
6
Exhibit 10.10
IN WITNESS WHEREOF, and intending to be legally bound, the Parties have executed the foregoing on the dates shown below.
EXECUTIVE IDEAYA BIOSCIENCES, INC.
__________________________ __________________________
By:
Title:
Date: ______________________ Date: _____________________
7